sunitinib malate — United Healthcare
soft tissue sarcoma
Initial criteria
- Diagnosis of one of the following:
- Alveolar soft part sarcoma (ASPS)
- Angiosarcoma
- Solitary fibrous tumor / hemangiopericytoma
- Extraskeletal myxoid chondrosarcoma
Reauthorization criteria
- Patient does not show evidence of progressive disease while on Sutent therapy
Approval duration
12 months